Waki, H., & Yamauchi, T. (2021). Body‐weight‐independent glucose‐lowering effect of the β3‐adrenergic receptor agonist mirabegron in humans. J Diabetes Investig.
Παραπομπή Chicago StyleWaki, Hironori, και Toshimasa Yamauchi. "Body‐weight‐independent Glucose‐lowering Effect of the β3‐adrenergic Receptor Agonist Mirabegron in Humans." J Diabetes Investig 2021.
Παραπομπή MLAWaki, Hironori, και Toshimasa Yamauchi. "Body‐weight‐independent Glucose‐lowering Effect of the β3‐adrenergic Receptor Agonist Mirabegron in Humans." J Diabetes Investig 2021.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.